Given the numerous effects of IL-4 and IL-13 in AD pathophysiology, including disruption of skin barrier, induction of bacterial binding and colonization, and recruitment of inflammatory cells, these cytokines and cytokine receptors have been attractive candidates for therapeutic targeting [34]. The gene discussed is IL4; the disease is Alzheimer disease.